arrow_back Back to App

Support for FSGS Awareness Day: Kidney Disease Impact on Health

This House of Representatives resolution supports designating June 10 as FSGS Awareness Day, focusing on a rare kidney disease. The aim is to increase public knowledge about this condition, which often leads to kidney failure and disproportionately affects minorities, while also backing research and access to treatment. Citizens will gain greater awareness of early detection and available support.
Key points
Designation of June 10 as FSGS Awareness Day to increase knowledge about this rare kidney disease.
Highlighting that FSGS often leads to kidney failure, requiring dialysis or transplants, incurring high healthcare costs.
Emphasizing that FSGS disproportionately affects minority populations, particularly African Americans, due to genetic predispositions.
Support for organizations and research aimed at early detection, developing new therapies, and improving access to treatment for FSGS patients.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HRES_507
Sponsor: Rep. Bilirakis, Gus M. [R-FL-12]
Process start date: 2025-06-12
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing support for the designation of June 10 as "FSGS Awareness Day".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HRES_507.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-06-12.

What are the main provisions?

Key points include:

  • Designation of June 10 as FSGS Awareness Day to increase knowledge about this rare kidney disease.
  • Highlighting that FSGS often leads to kidney failure, requiring dialysis or transplants, incurring high healthcare costs.
  • Emphasizing that FSGS disproportionately affects minority populations, particularly African Americans, due to genetic predispositions.
  • Support for organizations and research aimed at early detection, developing new therapies, and improving access to treatment for FSGS patients.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Bilirakis, Gus M. [R-FL-12].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-21.

CATEGORIES

Health